Application no. and date | 05740221.6 (espacenet) (Federated) (European Patent Register), 20050419 | Patent/reg. no. and date | DK/EP 1729777, 20090304 | Publication date | 20061213 | Priority no. and date | EP 04101664, 20040421 | EP pub. no. and date |
EP 1729777 20061213 | Effective date | | Applicant/owner | N.V. Organon, Kloosterstraat 6
5349 AB Oss, NL | Applicant ref. no. | 152737 | Inventor | MOOLENAAR, Sytske, Hyke, N.V. Organon
P.O. Box 20
NL-5340 BH OSS, NL, KEMPERMAN, Gerardus, Johannes, N.V. Organon
P. O. Box 20
NL-5340 BH Oss, NL, VAN DER VOORT MAARSCHALK, Kees, De Kamp 28
7731 AA Ommen, NL | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/55 (2006.01) , C07D 471/22 (2006.01) | Title | Farmaceutisk sammensætning omfattende et mirtazapinsalt | Int. application no. | EP2005051714 | Int. publication no. | WO2005102352 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|